Market Overview:
The global rubella virus nucleic acid detection kit market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of rubella, rising demand for nucleic acid detection kits for diagnosis and research applications, and technological advancements in nucleic acid detection kits. However, the high cost of advanced nucleic acid detection kits may restrain the growth of this market during the forecast period. Based on type, the global rubella virus nucleic acid detection kit market is segmented into DNA, RNA, and DNA/RNA. The DNA segment is expected to account for a major share of this market during the forecast period owing to its high sensitivity and specificity. Based on application, this market is divided into diagnosis and research applications.
Product Definition:
A Rubella Virus Nucleic Acid Detection Kit is a tool used to identify the presence of the rubella virus in a sample. The kit can be used to test blood, urine, and other body fluids for the virus. The detection of rubella virus in a sample can help to diagnose an infection and determine if treatment is necessary.
DNA:
DNA, it's usage and growth factor in rubella virus nucleic acid detection kit market is anticipated to grow significantly over the forecast period. The rubella virus consists of RNA (ribonucleic acid) and DNA (deoxyribonucleic acid). These are responsible for causing infection in humans by entering through the nose, mouth or eyes.
RNA:
RNA is a nucleic acid that acts as aribozyme in the presence of enzymecatalyzer. It is ribonucleic acid and consists of deoxynucleotide units. RNA can act as an mRNA ( messenger RNA) for protein synthesis or can be used for DNA sequencing, gene regulation, and modification.
Rubella virus uses viral RNA to infect host cells and multiply by budding inside the host cell cytoplasm.
Application Insights:
Rubella virus is a member of the Togaviridae family, genus Orthopoxvirus. It causes infection in humans and animals. In humans, rubella infection is known to cause mild disease characterized by feverish illness with rash that spreads over entire body and covers also face, ears and trunk. However severe infections have also been reported leading to hospitalization of patients. In such cases symptoms include stiff neck headache confusion eyesight problems hearing loss followed by pneumonia or other respiratory diseases complications etcetera (1).
Regional Analysis:
North America dominated the global market in 2017. This is attributed to increasing incidence of rubella and growing target population in this region. According to the data published by World Health Organization (WHO), around 14,000 cases of rubella were reported worldwide in 2017. The highest number of cases was recorded in Europe followed by North America during that year.
The Asia Pacific market is expected to grow at a lucrative rate over the forecast period owing to increase awareness about various vaccination programs for preventing diseases such as diphtheria, whooping cough, tetanus and measles among other infectious diseases caused by viruses similar to rubella virus which are preventable with vaccination programs conducted globally including Rubavirus vaccine developed by WHO & UNICEF along with other vaccines co-developed by Merck & Co., Inc.; Pfizer; sanofi; GlaxoSmithKline plc.; Novartis AG; FUJIFILM Diosynth Biotechnologies Corporation Ltd.
Growth Factors:
- Increasing incidence of rubella virus infections: The global incidence of rubella virus infections is increasing due to the spread of the virus through unvaccinated and under-vaccinated populations. This is driving the demand for diagnostic tests for early diagnosis and treatment.
- Growing awareness about rubella virus infections: There is growing awareness among healthcare professionals and patients about the symptoms, transmission, and prevention of rubella virus infections. This is leading to an increase in demand for diagnostic tests for early diagnosis and treatment.
- Technological advancements in nucleic acid detection kits: There has been a significant advancement in nucleic acid detection technology over the past few years, which has led to improved performance of nucleic acid detection kits. This is driving their adoption by clinical laboratories worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Rubella Virus Nucleic Acid Detection Kit Market Research Report
By Type
DNA, RNA, DNA/RNA
By Application
Diagnosis, Research
By Companies
Innovita, Liferiver, Mole, Bioperfectus, Tellgen, Sanway
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Rubella Virus Nucleic Acid Detection Kit Market Report Segments:
The global Rubella Virus Nucleic Acid Detection Kit market is segmented on the basis of:
Types
DNA, RNA, DNA/RNA
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diagnosis, Research
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Innovita
- Liferiver
- Mole
- Bioperfectus
- Tellgen
- Sanway
Highlights of The Rubella Virus Nucleic Acid Detection Kit Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- DNA
- RNA
- DNA/RNA
- By Application:
- Diagnosis
- Research
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Rubella Virus Nucleic Acid Detection Kit Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The Rubella Virus Nucleic Acid Detection Kit is a laboratory tool that can be used to detect the presence of rubella virus nucleic acid in a sample.
Some of the major companies in the rubella virus nucleic acid detection kit market are Innovita, Liferiver, Mole, Bioperfectus, Tellgen, Sanway.
The rubella virus nucleic acid detection kit market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Rubella Virus Nucleic Acid Detection Kit Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Rubella Virus Nucleic Acid Detection Kit Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Rubella Virus Nucleic Acid Detection Kit Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Rubella Virus Nucleic Acid Detection Kit Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Rubella Virus Nucleic Acid Detection Kit Market Size & Forecast, 2020-2028
4.5.1 Rubella Virus Nucleic Acid Detection Kit Market Size and Y-o-Y Growth
4.5.2 Rubella Virus Nucleic Acid Detection Kit Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 DNA
5.2.2 RNA
5.2.3 DNA/RNA
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Diagnosis
6.2.2 Research
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Rubella Virus Nucleic Acid Detection Kit Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Rubella Virus Nucleic Acid Detection Kit Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 DNA
9.6.2 RNA
9.6.3 DNA/RNA
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Diagnosis
9.10.2 Research
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 DNA
10.6.2 RNA
10.6.3 DNA/RNA
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Diagnosis
10.10.2 Research
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 DNA
11.6.2 RNA
11.6.3 DNA/RNA
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Diagnosis
11.10.2 Research
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 DNA
12.6.2 RNA
12.6.3 DNA/RNA
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Diagnosis
12.10.2 Research
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 DNA
13.6.2 RNA
13.6.3 DNA/RNA
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Diagnosis
13.10.2 Research
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Rubella Virus Nucleic Acid Detection Kit Market: Competitive Dashboard
14.2 Global Rubella Virus Nucleic Acid Detection Kit Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Innovita
14.3.2 Liferiver
14.3.3 Mole
14.3.4 Bioperfectus
14.3.5 Tellgen
14.3.6 Sanway
